跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Urlac - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Urlac
Approved
STANDARD
Urlac
Opsonin Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6bae6dbdef685924
Company
Opsonin Pharma Limited
Type
Standard
Approval Details
Approval Id
6bae6dbdef685924
Drug Approval Philippines Name
Urlac
Product Name
Urlac
Registration Number
DRP-8109-02
Brand Name
Urlac
Generic Name
Ursodeoxycholic Acid
Dosage Form
Film-Coated Tablet
Dosage Strength
300 mg
Manufacturer
Opsonin Pharma Limited
Importer
Jazmark Pharmaceutical
Distributor
Bridgemark Marketing
Issuance Date
24 November 2021
Expiry Date
19 August 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6bae6dbdef685924
Type
Standard
Back to Philippines FDA Approvals